PRISM MarketView

IceCure’s ProSense® Demonstrates “Zero Local Recurrence” of Breast Cancer

New York, May 07, 2024 - PRISM MarketView - IceCure Medical (Nasdaq: ICCM) saw its share price rise by 1.75% in intraday trading on Tuesday after the company announced that results from an independent study of patients in Japan demonstrated zero local recurrence of breas...

7 May 2024

Beauty Centric Business Shows Strength as Coty (COTY) Announces Earnings

New York, May 07, 2024 - PRISM MarketView - The beauty product manufacturer Coty, Inc. (COTY) announced Q3 earnings yesterday, after the close. The company came in just shy on Q3 EPS $0.05 vs FactSet $0.06 but beat on revenues $1.39B vs FactSet 1.37B and adjusted EBITDA ...

7 May 2024

Lipella Pharmaceuticals Advances With Multiple Near-Term Catalysts and Strategic Focus on Rare Diseases

New York, May 07, 2024 - PRISM MarketView - Lipella Pharmaceuticals (Nasdaq: LIPO) is making significant strides with its innovative liposomal delivery technologies and targeted therapies for oral mucosa and bladder conditions. As it enters a period rich with clinical an...

7 May 2024

Gossamer Enters Global Collaboration and License Agreement Valued at $486M

New York, May 06, 2024 - PRISM MarketView - Biopharmaceutical company Gossamer Bio (Nasdaq: GOSS) has entered a global collaboration and license agreement with the Chiesi Farmaceutici S.p.A (Chiesi Group), an international, research-focused biopharmaceutical group. Toget...

6 May 2024

AIM ImmunoTech Combination Therapy Well Tolerated in Late-Stage Pancreatic Cancer

New York, May 03, 2024 - PRISM MarketView - AIM ImmunoTech’s (NYSE American: AIM) combination therapy for the treatment of late-stage pancreatic cancer has demonstrated safety and tolerability in a Phase 1b/2 study being conducted by the company in the Netherlands. No tr...

3 May 2024

Vaxart Reports Positive Topline Results in Norovirus Vaccine Trial in Lactating Women

New York, May 03, 2024 - PRISM MarketView - Vaxart, Inc. (Nasdaq: VXRT) has reported positive topline results from a Phase 1 clinical trial evaluating its oral pill bivalent norovirus vaccine candidate in lactating women. The company’s long-term goal is to provide protec...

3 May 2024

Sunrun Supports Puerto Rico with Dependable Solar Energy

New York, May 03, 2024 - PRISM MarketView - Clean energy provider, Sunrun (Nasdaq: RUN), has announced that it has enrolled nearly 1,800 customers in its PowerOn Puerto Rico virtual power plant. Sunrun, which has a market cap of $2.42 billion, saw its stock rise 8.74% in...

3 May 2024

Metagenomi Shares Drop as Moderna Collaboration Terminated

New York, May 02, 2024 - PRISM MarketView - Metagenomi Inc’s (Nasdaq: MGX) share price dropped by almost 12.0% in intraday trading on Thursday after the company announced that it had mutually agreed to terminate a collaboration with Moderna (Nasdaq: MRNA). Moderna’s shar...

2 May 2024

Sunnova Stock Shines, Jumps 22% on Earnings Beat

New York, May 02, 2024 - PRISM MarketView - Sunnova Energy International (NYSE: NOVA) stock soared 22% this morning, following a surprising earnings report last night that surpassed Wall Street expectations. While analysts had predicted a loss of $0.73 per share on sales...

2 May 2024

Olaplex (OLPX) Net Sales Drop Looks Hairy, Investors Find Beauty in Other Earnings Metrics as Stock Trades Up, ~20%

New York, May 02, 2024 - PRISM MarketView -The tech-driven beauty retailer and PRISM Consumer Products Index company, Olaplex Holdings, Inc. (OLPX) announced its Q1 financial results today as EPS came in line $0.03 vs FactSet $0.03, quarterly revenues beat $98.9M vs Fact...

2 May 2024